NCT03487978

Brief Summary

The purpose of this study is to identify a core fMRI feature that determines migrainous brain and plastic fMRI features that changes with longitudinal courses of migraine.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 24, 2017

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

March 27, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 4, 2018

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2023

Completed
Last Updated

March 20, 2020

Status Verified

March 1, 2020

Enrollment Period

4.6 years

First QC Date

March 27, 2018

Last Update Submit

March 18, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Core fMRI features for migraine brain

    Among significant networks identified by ICA, we will identify altered networks which remain unchanged in follow-up resting-state fMRI in 1 year.

    1-year follow-up (2nd year)

Secondary Outcomes (2)

  • Candidate fMRI features for migraine

    Baseline (1st year)

  • Dynamic fMRI features for disease severity

    1-year follow-up (2nd year)

Study Arms (2)

Migraineurs

Patients diagnosed with migraine based on the ICHD-3 beta will undergo 3-tesla resting-state functional MRI.

Diagnostic Test: resting-state functional MRI

Control

Normal controls without headaches will undergo 3-tesla resting-state functional MRI.

Diagnostic Test: resting-state functional MRI

Interventions

1. To ensure inter-ictal fMRI, confirm that the subject has no migraine for at least 48 hours before the procedure. 2. Record the time difference between the date on the day of fMRI and the date of the last headache attack and record whether the headache on the day of fMRI is absent or not. 3. On the third day after MRI, examine whether the subject has headache or not.

ControlMigraineurs

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Controls and migraineurs who visited to a single university hospital

You may qualify if:

  • Migrainuers :
  • age 18-50 years
  • migraine with or without aura as defined by the third edition of the International Classification of Headache Disorders (ICHD-3 beta)
  • if female, before the onset of menopausal
  • Controls:
  • age 18-50 years
  • no headache disorder other than Infrequent episodic tension-type headache as defined by the ICHD-3 beta

You may not qualify if:

  • contraindicated to MRI
  • pregnancy
  • require sedation treatment because of claustrophobia when performing MRI
  • predicted to be unable to write the headache diary due to cognitive decline
  • refuse study procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samsung Medical Center

Seoul, South Korea

Location

MeSH Terms

Conditions

Migraine Disorders

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Mi Ji Lee, MD

    Samsung Medical Center, Sungkyunkwan University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD, Professor of neurology

Study Record Dates

First Submitted

March 27, 2018

First Posted

April 4, 2018

Study Start

July 24, 2017

Primary Completion

February 28, 2022

Study Completion

February 28, 2023

Last Updated

March 20, 2020

Record last verified: 2020-03

Locations